Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Tri Chemical, 11% Decrease in Ordinary Profit for The Current Fiscal Year
4369 Tri Chemical Laboratories Inc. 【J-GAAP】
Earnings ReportTri Chemical Laboratories Inc. <4369> [TSE Prime] announced its financial results after the market closed on March 13th (15:30). The consolidated ordinary profit for the fiscal year ended January 2026 increased by 7.7% from the previous period to 7.09 billion yen. However, for the fiscal year ending January 2027, the consolidated ordinary profit is expected to decrease by 11.1% from the previous period to 6.30 billion yen.
In the most recent three-month period, from November to January (4Q), the consolidated ordinary profit decreased to 1.63 billion yen, a 26.9% decrease compared to the same period last year. The operating profit margin decreased from 30.2% in the same period last year to 22.8%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan, 2024 | 11,246 | 1,947 | 3,276 | 2,470 | 76.0 | 30 | Mar 15, 2024 | J-GAAP |
| Jan, 2025 | 18,905 | 5,256 | 6,583 | 4,961 | 152.7 | 35 | Mar 14, 2025 | J-GAAP |
| Jan, 2026 | 23,883 | 5,902 | 7,090 | 5,515 | 169.7 | 35 | Mar 13, 2026 | J-GAAP |
| YoY | +26.3% | +12.3% | +7.7% | +11.2% | +11.2% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan, 2026 Guidance | 23,000 | 5,500 | 6,530 | 4,800 | 147.7 | 35 | Aug 29, 2025 | J-GAAP |
| Jan, 2026 Results | 23,883 | 5,902 | 7,090 | 5,515 | 169.7 | 35 | Mar 13, 2026 | J-GAAP |
| Revision Rate | +3.8% | +7.3% | +8.6% | +14.9% | +14.9% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Feb - Jul, 2025 | 12,375 | 3,177 | 3,800 | 2,776 | 85.5 | 0 | Aug 29, 2025 | J-GAAP |
| Feb - Jul, 2026 Guidance | 13,700 | 2,960 | 3,090 | 2,190 | 67.4 | 0 | Mar 13, 2026 | J-GAAP |
| YoY | +10.7% | -6.8% | -18.7% | -21.1% | -21.1% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan, 2025 | 18,905 | 5,256 | 6,583 | 4,961 | 152.7 | 35 | Mar 14, 2025 | J-GAAP |
| Jan, 2026 | 23,883 | 5,902 | 7,090 | 5,515 | 169.7 | 35 | Mar 13, 2026 | J-GAAP |
| Jan, 2027 Guidance | 27,000 | 6,000 | 6,300 | 4,600 | 141.6 | 35 | Mar 13, 2026 | J-GAAP |
| YoY | +13.1% | +1.7% | -11.1% | -16.6% | -16.6% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Nov - Jan, 2024 | 5,800 | 1,754 | 2,232 | 1,735 | 53.4 | 30.2 | Mar 14, 2025 | J-GAAP |
| Feb - Apr, 2025 | 6,569 | 1,712 | 1,640 | 1,207 | 37.2 | 26.1 | May 30, 2025 | J-GAAP |
| May - Jul, 2025 | 5,806 | 1,465 | 2,160 | 1,569 | 48.3 | 25.2 | Aug 29, 2025 | J-GAAP |
| Aug - Oct, 2025 | 5,635 | 1,384 | 1,658 | 1,245 | 38.3 | 24.6 | Nov 28, 2025 | J-GAAP |
| Nov - Jan, 2025 | 5,873 | 1,341 | 1,632 | 1,494 | 46.0 | 22.8 | Mar 13, 2026 | J-GAAP |
| YoY | +1.3% | -23.5% | -26.9% | -13.9% | -13.9% |
Related Articles
itamiarts, 10% Increase in Ordinary Profit, Record High for The First Time in Two Years
Japan Eyewear, 16% Increase in Net Income, Record High for The First Time in Two Years, Dividend Raised by 2 Yen
FreeBit, May-Jan (Cumulative 3Q) Ordinary Profit Increases by 5%
BrightPath Biotherapeutics, Net Income Forecast for the Fiscal Year Loss Widened in Downward Revision
Kura Sushi, Nov-Jan (1Q) Ordinary Profit Increases by 12%
OSG, 2.3 times Increase in Ordinary Profit for The Current Fiscal Year
TOWA BANK, Net Income Forecast for the Fiscal Year Revised Downward to a Loss
KOBE BUSSAN, Nov-Jan (1Q) Ordinary Profit Decreases by 43%
Morozoff Limited, 5% Increase in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 2 Yen, Plan to Continue the 16 Yen Policy This Fiscal Year as Well
SAKURASAKU PLUS, First Half Ordinary Profit Increases by 3.1 times, Nov-Jan Ordinary Profit Increases by 43%